Gitterman Quoted in Bloomberg BNA on FDA's Drug Tracking System

Life Sciences and Healthcare Regulatory associate Abraham Gitterman was quoted in a recent Bloomberg BNA article, "Industry Wants FDA Help, Guidance on New Drug Tracking System," which investigates the FDA's implementation of a national drug tracking system designed to prevent counterfeit or suspect medications from entering the marketplace.

» Read the full article (subscription required).